MetaCap

Who Owns Xenon Pharmaceuticals Stock?

NASDAQ: XENEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

37.04-0.52 (-1.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
114.61%
Institutional holders
432
  • Institutions 99.8%
  • Insiders 0.2%
  • Public and other 0.0%

Who owns Xenon Pharmaceuticals stock?

Institutional investors own about 114.6% of Xenon Pharmaceuticals's shares, spread across 432 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.17% of XENE.

The largest institutional holders are FMR, LLC (11.95%), Blackrock Inc. (7.78%) and Avoro Capital Advisors LLC (5.98%). Together, the top 10 institutions control 49.5% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their XENE positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of XENE

Xenon Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
FMR, LLC11.55M11.95%+19.8%
Blackrock Inc.7.52M7.78%+33.4%
Avoro Capital Advisors LLC5.78M5.98%0.0%
Polar Capital Holdings PLC4.57M4.73%+3.8%
Driehaus Capital Management, LLC4.42M4.57%-1.6%
Jupiter Topco LLC4.19M4.33%+100.0%
Price (T.Rowe) Associates Inc3.25M3.36%+144.3%
Capital International Investors2.36M2.44%-0.1%
T. Rowe Price Investment Management, Inc.2.17M2.24%+127.8%
State Street Corporation2.06M2.13%+4.5%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of XENE

Xenon Pharmaceuticals top fund holders
FundShares% Held
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total 3.58M3.71%
SmallCap World Fund Inc2.81M2.91%
iShares Trust-iShares Russell 2000 ETF2.54M2.63%
T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App1.27M1.32%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.07M1.11%
JPMorgan Trust II-JPMorgan Mid Cap Growth Fund962.10K1.00%
iShares Trust-iShares Russell 2000 Growth ETF918.06K0.95%
T. Rowe Price New Horizons Fund, Inc.902.59K0.93%
Fidelity Select Portfolios-Select Health Care Portfolio860.00K0.89%
T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U.853.24K0.88%

Frequently asked questions

Who is the largest shareholder of Xenon Pharmaceuticals?

FMR, LLC is the largest institutional shareholder of XENE, owning 11.95% of shares outstanding (11.55M shares) as of its latest 13F filing.

What percentage of Xenon Pharmaceuticals is owned by institutions?

Institutions own about 114.6% of XENE shares and 114.8% of the public float.

How much of Xenon Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 0.17% of XENE shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related